The long pentraxin 3 and its role in autoimmunity. Seminars in arthritis and rheumatism, vol.39, pp.38-54, 2009. ,
Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus, Rheumatology, vol.48, issue.4, pp.442-446, 2009. ,
Detection of Anti-Pentraxin-3 ,
, Autoantibodies in ANCA-Associated Vasculitis, PloS one, vol.2016, issue.1, p.147091
Pentraxins in innate immunity: lessons from PTX3. Cell and tissue research, vol.343, pp.237-286, 2011. ,
Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component, Journal of immunology, vol.165, issue.2, pp.1030-1035, 2000. ,
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility, Annual review of immunology, vol.23, pp.337-66, 2005. ,
C-reactive protein: a critical update, The Journal of clinical investigation, vol.111, issue.12, pp.1805-1817, 2003. ,
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction, Circulation, vol.110, issue.16, pp.2349-54, 2004. ,
Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients, Critical care medicine, vol.29, issue.7, pp.1404-1411, 2001. ,
The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. The Journal of experimental medicine, vol.204, pp.793-804, 2007. ,
Netting neutrophils in autoimmune small-vessel vasculitis, Nature medicine, vol.15, issue.6, pp.623-628, 2009. ,
Binding of human C-reactive protein to bacteria, Infection and immunity, vol.38, issue.1, pp.392-397, 1982. ,
Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein, The Journal of experimental medicine, vol.187, issue.4, pp.631-671, 1998. ,
Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen, Proceedings of the National Academy of Sciences of the United States of America, vol.97, pp.14584-14593, 2000. ,
Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice, Infection and immunity, vol.68, issue.10, pp.5652-5658, 2000. ,
Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus, PloS one, vol.6, issue.5, p.20118, 2011. ,
Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications, Frontiers in immunology, vol.5, p.354, 2014. ,
Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. Cell death and differentiation, vol.16, pp.1630-1670, 2009. ,
The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages, Arthritis and rheumatism, vol.50, issue.8, pp.2667-74, 2004. ,
Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein, Arthritis and rheumatism, vol.54, issue.1, pp.325-360, 2006. ,
C-reactive protein (CRP) and autoimmune disease: facts and conjectures, Clinical & developmental immunology, vol.11, issue.3-4, pp.221-227, 2004. ,
Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology, vol.112, pp.255-64, 2004. ,
High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus, vol.20, pp.588-97, 2011. ,
C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro. The Journal of experimental medicine, vol.161, pp.1344-56, 1985. ,
Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases, Clinical and experimental immunology, vol.113, issue.3, pp.327-359, 1998. ,
C-reactive protein: how conformational changes influence inflammatory properties, Cell cycle, vol.8, issue.23, pp.3885-92, 2009. ,
Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus, Annals of the New York Academy of Sciences, pp.227-266, 1108. ,
Anti-CRP autoantibody levels correlate with disease activity in systemic lupus erythematosus. Seminars in arthritis and rheumatism, vol.35, p.65, 2005. ,
Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome, The Journal of rheumatology, vol.33, issue.10, pp.1980-1986, 2006. ,
Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis, Arthritis research & therapy, vol.11, issue.6, p.188, 2009. ,
Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions, Human immunology, vol.69, issue.12, pp.840-844, 2008. ,
Modified C-reactive protein might be a target autoantigen of TINU syndrome, Clinical journal of the American Society of Nephrology : CJASN, vol.6, issue.1, pp.93-100, 2011. ,
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Annals of the rheumatic diseases, vol.64, pp.1698-702, 2005. ,
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus, Annals of the rheumatic diseases, vol.2010, issue.9, pp.1704-1714 ,
Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them?, Clinical reviews in allergy & immunology, vol.35, pp.47-58, 2008. ,
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annual review of pathology, vol.8, pp.139-60, 2013. ,
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis, The Journal of clinical investigation, vol.123, issue.4, pp.1773-83, 2013. ,
Emergency testing for antineutrophil cytoplasmic antibodies combined with a dialog-based policy between clinician and biologist: effectiveness for the diagnosis of ANCAassociated vasculitis. Internal and emergency medicine, 2014. ,